Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.28 USD | +0.88% | +7.29% | -81.67% |
05-14 | Transcript : Vivos Therapeutics, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
05-14 | Vivos Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-81.67% | 6.74M | |
+73.45% | 12.42B | |
-19.60% | 7.81B | |
+4.25% | 6.4B | |
+13.24% | 5.45B | |
+38.48% | 5.01B | |
-17.30% | 4.84B | |
-19.78% | 4.19B | |
-28.72% | 2.69B | |
+48.43% | 2.39B |
- Stock Market
- Equities
- VVOS Stock
- News Vivos Therapeutics, Inc.
- Vivos Therapeutics Receives FDA 510(k) Clearance for Oral Device Treatment for Sleep Apnea; Shares Soar